In bladder cancer, lentiviral transduction of hBM-MSCs to express miR-139-5p resulted in EVs that targeted kinesin family member 3a (KIF3A), activated cyclin-dependent kinase inhibitor 1 (p21), and suppressed tumor progression [43]. Here, CDKN1A is linked to neoplasm.